BioCentury | May 1, 2020
Product Development

How the U.K. healthcare sector is leveraging its strengths to beat COVID-19

Crisis is the mother of invention and COVID-19 is no exception. But amid all the gloom are signs of a nascent revolution in how we create and develop new drugs, vaccines and diagnostics. The U.K....
BioCentury | Nov 16, 2015
Regulation

Demanding rights

Among several ongoing experiments with policies and programs to facilitate preapproval access to drugs, the most controversial is being conducted by state legislatures. Patients and their families, frustrated by lack of access to experimental drugs,...
BioCentury | Mar 2, 2015
Clinical News

Veregen sinecatechins regulatory update

Medigene said Veregen sinecatechins to treat external genital and perianal warts in immunocompetent patients ages >=18 was recommended for approval under the EU’s Mutual Recognition Procedure in 8 countries. The company expects to begin the...
BioCentury | Oct 6, 2014
Clinical News

Veregen sinecatechins regulatory update

Medigene submitted MAAs in 8 European countries for Veregen sinecatechins to treat external genital and perianal warts under the Mutual Recognition Procedure. The company expects a decision next half from the U.K., Ireland, Italy, Portugal,...
BioCentury | Jan 27, 2014
Finance

Taiwan's biotech boom

...rabbit mAb service play Epitomics Inc. , where he first gained experience with Taiwan's capital markets. Epitomics...
BioCentury | Oct 14, 2013
Company News

Medigene, Sinphar Pharmaceutical sales and marketing update

SynCore Biotechnology Co. Ltd. , a JV between Sinphar and the National Health Research Institute of Taiwan (Taipei, Taiwan), launched Veregen sinecatechins in Taiwan to treat genital warts. Medigene said Taiwan is the first Asian country...
BioCentury | Sep 16, 2013
Clinical News

Veregen sinecatechins regulatory update

Medigene said Canada approved Veregen sinecatechins to treat genital warts. Medigene said Canadian partner Triton is expected to launch the product in the country next half. The topical formulation of polyphenols extracted from green tea...
BioCentury | Aug 12, 2013
Finance

Abiding no more

...Abiding no more Unable to raise venture money when it spun out of service play Epitomics Inc....
...people." He said the funding may last four to five years. Abcam plc (LSE:ABC) acquired Epitomics...
BioCentury | Aug 5, 2013
Company News

Medigene, Will-Pharma sales and marketing update

Medigene said Will-Pharma launched Veregen sinecatechins in the Netherlands to treat genital warts. In 2011, Will-Pharma received exclusive marketing rights to Veregen in Belgium, the Netherlands and Luxembourg to treat genital warts. Medigene is eligible...
BioCentury | Jun 17, 2013
Clinical News

Veregen sinecatechins regulatory update

Medigene said Taiwan approved Veregen sinecatechins ointment to treat external genital warts. Medigene expects the SynCore Biotechnology Co. Ltd. subsidiary of Sinphar Pharmaceutical Co. Ltd. (Taiwan:1734, Taipei City, Taiwan) to launch the product in Taiwan...
Items per page:
1 - 10 of 86
BioCentury | May 1, 2020
Product Development

How the U.K. healthcare sector is leveraging its strengths to beat COVID-19

Crisis is the mother of invention and COVID-19 is no exception. But amid all the gloom are signs of a nascent revolution in how we create and develop new drugs, vaccines and diagnostics. The U.K....
BioCentury | Nov 16, 2015
Regulation

Demanding rights

Among several ongoing experiments with policies and programs to facilitate preapproval access to drugs, the most controversial is being conducted by state legislatures. Patients and their families, frustrated by lack of access to experimental drugs,...
BioCentury | Mar 2, 2015
Clinical News

Veregen sinecatechins regulatory update

Medigene said Veregen sinecatechins to treat external genital and perianal warts in immunocompetent patients ages >=18 was recommended for approval under the EU’s Mutual Recognition Procedure in 8 countries. The company expects to begin the...
BioCentury | Oct 6, 2014
Clinical News

Veregen sinecatechins regulatory update

Medigene submitted MAAs in 8 European countries for Veregen sinecatechins to treat external genital and perianal warts under the Mutual Recognition Procedure. The company expects a decision next half from the U.K., Ireland, Italy, Portugal,...
BioCentury | Jan 27, 2014
Finance

Taiwan's biotech boom

...rabbit mAb service play Epitomics Inc. , where he first gained experience with Taiwan's capital markets. Epitomics...
BioCentury | Oct 14, 2013
Company News

Medigene, Sinphar Pharmaceutical sales and marketing update

SynCore Biotechnology Co. Ltd. , a JV between Sinphar and the National Health Research Institute of Taiwan (Taipei, Taiwan), launched Veregen sinecatechins in Taiwan to treat genital warts. Medigene said Taiwan is the first Asian country...
BioCentury | Sep 16, 2013
Clinical News

Veregen sinecatechins regulatory update

Medigene said Canada approved Veregen sinecatechins to treat genital warts. Medigene said Canadian partner Triton is expected to launch the product in the country next half. The topical formulation of polyphenols extracted from green tea...
BioCentury | Aug 12, 2013
Finance

Abiding no more

...Abiding no more Unable to raise venture money when it spun out of service play Epitomics Inc....
...people." He said the funding may last four to five years. Abcam plc (LSE:ABC) acquired Epitomics...
BioCentury | Aug 5, 2013
Company News

Medigene, Will-Pharma sales and marketing update

Medigene said Will-Pharma launched Veregen sinecatechins in the Netherlands to treat genital warts. In 2011, Will-Pharma received exclusive marketing rights to Veregen in Belgium, the Netherlands and Luxembourg to treat genital warts. Medigene is eligible...
BioCentury | Jun 17, 2013
Clinical News

Veregen sinecatechins regulatory update

Medigene said Taiwan approved Veregen sinecatechins ointment to treat external genital warts. Medigene expects the SynCore Biotechnology Co. Ltd. subsidiary of Sinphar Pharmaceutical Co. Ltd. (Taiwan:1734, Taipei City, Taiwan) to launch the product in Taiwan...
Items per page:
1 - 10 of 86